What Researchers Did
Researchers conducted a clinical pilot study to assess if hyperbaric oxygen (HBO) enhanced photodynamic therapy (PDT) in patients with advanced esophageal carcinoma, comparing PDT alone to PDT under HBO conditions.
What They Found
Both PDT alone (14 patients) and PDT with HBO (17 patients) improved dysphagia and stenosis diameter, with no significant differences between groups (P=0.36 and P=0.14, respectively). However, tumor length significantly decreased more in the PDT/HBO group compared to PDT alone (P=0.002).
What This Means for Canadian Patients
This pilot study suggests that adding hyperbaric oxygen to photodynamic therapy might offer an advantage in reducing tumor length for advanced esophageal cancer. However, it did not show significant improvements in dysphagia or stenosis diameter compared to PDT alone.
Canadian Relevance
This study has no stated Canadian connection.
Study Limitations
As a pilot study, its main limitation is the small sample size, which restricts the generalizability of the findings.